Background. Breast invasive carcinoma (BRCA) is not a single disease as each subtype has a distinct morphology structure. Although several computational methods have been proposed to conduct breast cancer subtype identification, the specific interaction mechanisms of genes involved in the subtypes are still incomplete. To identify and explore the corresponding interaction mechanisms of genes for each subtype of breast cancer can impose an important impact on the personalized treatment for different patients. Methods. We integrate the biological importance of genes from the gene regulatory networks to the differential expression analysis and then obtain the weighted differentially expressed genes (weighted DEGs). A gene with a high weight me...
Abstract Breast cancer is heterogeneous in prognoses and drug responses. To organize breast cancers ...
Cancer subtype information is significant to understand tumour heterogeneity. Present methods to fin...
Cancer is a heterogeneity genetic disease with huge phenotypic alterations among dissimilar cancers ...
Breast cancer is a complex disease that can be classified into at least 10 different molecular subty...
<div><p>Background</p><p>Identifying cancer subtypes is an important component of the personalised m...
BACKGROUND:Identifying cancer subtypes is an important component of the personalised medicine framew...
World wide, one in nine women is diagnosed with breast cancer in her lifetime and breast cancer is t...
Despite the power of high-throughput genomics, most non-coding RNA (ncRNA) biotypes remain hard to i...
Breast cancer is one of the leading causes of death in women. Even with advances in early-stage brea...
SINCE the advent of array-based technology and the sequencing of the human genome, scientistsattempt...
Background. It has been known that microRNAs (miRNAs) regulate the expression of multiple proteins a...
Breast Cancer comprises multiple subtypes implicated in prognosis. Existing stratification methods r...
Breast cancer is a heterogeneous disease classified into four main subtypes with different clinical ...
Abstract Background Identification of cancer subtypes is of great importance to facilitate cancer di...
Summarization: The path to personalized medicine requires the stratification of patients based on th...
Abstract Breast cancer is heterogeneous in prognoses and drug responses. To organize breast cancers ...
Cancer subtype information is significant to understand tumour heterogeneity. Present methods to fin...
Cancer is a heterogeneity genetic disease with huge phenotypic alterations among dissimilar cancers ...
Breast cancer is a complex disease that can be classified into at least 10 different molecular subty...
<div><p>Background</p><p>Identifying cancer subtypes is an important component of the personalised m...
BACKGROUND:Identifying cancer subtypes is an important component of the personalised medicine framew...
World wide, one in nine women is diagnosed with breast cancer in her lifetime and breast cancer is t...
Despite the power of high-throughput genomics, most non-coding RNA (ncRNA) biotypes remain hard to i...
Breast cancer is one of the leading causes of death in women. Even with advances in early-stage brea...
SINCE the advent of array-based technology and the sequencing of the human genome, scientistsattempt...
Background. It has been known that microRNAs (miRNAs) regulate the expression of multiple proteins a...
Breast Cancer comprises multiple subtypes implicated in prognosis. Existing stratification methods r...
Breast cancer is a heterogeneous disease classified into four main subtypes with different clinical ...
Abstract Background Identification of cancer subtypes is of great importance to facilitate cancer di...
Summarization: The path to personalized medicine requires the stratification of patients based on th...
Abstract Breast cancer is heterogeneous in prognoses and drug responses. To organize breast cancers ...
Cancer subtype information is significant to understand tumour heterogeneity. Present methods to fin...
Cancer is a heterogeneity genetic disease with huge phenotypic alterations among dissimilar cancers ...